Graymark Healthcare Signs Five New Provider Contracts for Sleep Medicine Services

OKLAHOMA CITY, Jan. 11, 2011 /PRNewswire/ -- Graymark Healthcare, Inc. (Nasdaq: GRMH), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), signed five additional agreements for its comprehensive sleep medicine services in the fourth quarter of 2010.

These new customers bring the aggregate number of signed agreements during the fourth quarter to seven, and a total of 12 for 2010. The locations of the new Graymark sleep centers include:

• Kearney County Health Services of Minden, Nebraska
• Grady Memorial Hospital of Chickasha, Oklahoma
• Carrus Specialty Hospital of Sherman, Texas
• Wise Regional Hospital of Decatur, Texas
• Glen Rose Medical Center of Glen Rose, Texas

Patients in the geographic regions these hospitals serve can now receive sleep medicine care in familiar surroundings, while Graymark Healthcare ensures comprehensive, state-of-the-art services.

"Grady Memorial Hospital is very excited to partner with Graymark," said Mike Nunamaker, CEO of Grady Memorial Hospital. "Between their experience and our established clinical excellence, we look forward to providing the residents of Grady and surrounding counties with exceptional comprehensive care."

Including today's new contracts, Graymark now operates a total of 98 sleep laboratories, comprised of 25 standalone or IDTF facilities in large communities and 73 hospital, provider or rural outreach sites. While these care environments may vary based on community need, Graymark ensures that the quality and comprehensiveness of the services provided remain consistently at the highest standard.

According to Stanton Nelson, chairman and CEO of Graymark Healthcare: "With more than 50 million Americans suffering from some form of sleep disorder, people in all sized communities need and deserve state-of-the-art care to remedy sleep disorders. "Graymark has established viable business models that allow us to provide these services in a local and controlled environment, while ensuring follow-up therapies and clinical support are readily available."

In addition to treating all sleep disorders including narcolepsy, insomnia, and restless leg syndrome; Graymark specializes in the treatment of sleep apnea, a sleep disorder characterized by abnormal pauses in breathing. Each pause or "apnea" can last from a few seconds to minutes, and can occur from five to more than 30 times per hour. OSA is the most common form of apnea and occurs when the soft tissue in the airway obstructs breathing. The proper diagnosis and treatment of OSA is critical due to the many significant associated health risks, including stroke and cardiac disease.

Graymark Healthcare's effective five step clinical approach to managing sleep disorders includes a convenient referral process, accurate and timely assessment, diagnosis, treatment and long-term follow-up to maximize patient compliance. All steps are managed by a board certified Sleep Medicine physician. To find out more or to locate a sleep center near you, visit www.graymarkhealthcare.com.

About Graymark Healthcare

Headquartered in Oklahoma City, Okla., Graymark Healthcare Inc. (NASDAQ:GRMH) is the nation's second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 98 sleep laboratories throughout the United States, including standalone or IDTF facilities, rural outreach sites and hospital or provider agreements. For more information, visit www.graymarkhealthcare.com.

This press release may contain forward-looking statements that are based on the Company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the current economic climate and other risks and uncertainties, including those enumerated and described in the Company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at www.sec.gov. Unless otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Graymark Healthcare, Inc.